• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).

作者信息

Zhao Tie, Peng Liang

机构信息

Institute of Pathogenic Biology and Key Laboratory of Special Pathogen Prevention and Control of Hunan Province, Hengyang Medical College, University of South China, Hengyang, 421001, China.

Guangzhou Key Laboratory of Enhanced Recovery After Abdominal Surgery, Department of Clinical Laboratory, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510700, China.

出版信息

Diabetes Metab Syndr. 2021 Jan-Feb;15(1):21. doi: 10.1016/j.dsx.2020.11.017. Epub 2020 Nov 25.

DOI:10.1016/j.dsx.2020.11.017
PMID:33279832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7687361/
Abstract
摘要

相似文献

1
Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).致编辑的信：关于“59例冠状病毒病（COVID-19）患者使用他汀类药物的利弊”一文的回应（雷，S等人）
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):21. doi: 10.1016/j.dsx.2020.11.017. Epub 2020 Nov 25.
2
Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study".卡尔莫纳等人就文章《他汀类药物对COVID-19相关结局的有益影响——简要报告：一项基于全国人群的队列研究》所写的信。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):e280-e281. doi: 10.1161/ATVBAHA.121.316224. Epub 2021 Apr 21.
3
Statins in COVID-19: A new ray of hope.新冠疫情中的他汀类药物：一线新希望。
Heart Lung. 2020 Nov-Dec;49(6):887-889. doi: 10.1016/j.hrtlng.2020.07.012. Epub 2020 Aug 11.
4
Response to: Use of statins in patients with COVID-19.回应：新冠病毒疾病患者使用他汀类药物的情况
QJM. 2020 Aug 1;113(8):606-607. doi: 10.1093/qjmed/hcaa173.
5
Use of statins in patients with COVID-19.他汀类药物在新冠肺炎患者中的应用。
QJM. 2020 Aug 1;113(8):604-605. doi: 10.1093/qjmed/hcaa172.
6
Statins and other drugs: Facing COVID-19 as a vascular disease.他汀类药物及其他药物：将新冠病毒病视为一种血管疾病来应对
Pharmacol Res. 2020 Sep;159:105033. doi: 10.1016/j.phrs.2020.105033. Epub 2020 Jun 17.
7
Meta-analysis of Effect of Statins in Patients with COVID-19.他汀类药物对新型冠状病毒肺炎患者影响的荟萃分析
Am J Cardiol. 2020 Nov 1;134:153-155. doi: 10.1016/j.amjcard.2020.08.004. Epub 2020 Aug 12.
8
Are statins safe in patients with COVID-19?他汀类药物对新冠肺炎患者安全吗？
J Clin Lipidol. 2020 Jul-Aug;14(4):396-397. doi: 10.1016/j.jacl.2020.06.009. Epub 2020 Jun 22.
9
Teaching Old Drugs New Tricks: Statins for COVID-19?老药新用：他汀类药物治疗 COVID-19？
Cell Metab. 2020 Aug 4;32(2):145-147. doi: 10.1016/j.cmet.2020.07.006.
10
Statin therapy in COVID-19 infection.新冠病毒感染中的他汀类药物治疗。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.

引用本文的文献

1
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry.富含胆固醇的脂筏作为 SARS-CoV-2 进入的平台。
Front Immunol. 2021 Dec 16;12:796855. doi: 10.3389/fimmu.2021.796855. eCollection 2021.
2
Anti-flavivirus Properties of Lipid-Lowering Drugs.降脂药物的抗黄病毒特性。
Front Physiol. 2021 Oct 7;12:749770. doi: 10.3389/fphys.2021.749770. eCollection 2021.
3
The Fatty Acid Lipid Metabolism Nexus in COVID-19.COVID-19 中的脂肪酸脂质代谢关联。
Viruses. 2021 Jan 11;13(1):90. doi: 10.3390/v13010090.

本文引用的文献

1
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).在2019冠状病毒病（COVID-19）患者中使用他汀类药物的利弊。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1225-1229. doi: 10.1016/j.dsx.2020.07.011. Epub 2020 Jul 11.
2
Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.辛伐他汀与克拉霉素联合用药引起的横纹肌溶解症。
J Neurol. 2009 Jul;256(7):1182-3. doi: 10.1007/s00415-009-5078-6. Epub 2009 Mar 1.
3
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.两例患者在联合使用大环内酯类抗生素后出现辛伐他汀相关性横纹肌溶解症。
Pharmacotherapy. 2007 Apr;27(4):603-7. doi: 10.1592/phco.27.4.603.
4
Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.辛伐他汀与胺碘酮相互作用导致横纹肌溶解、氮质血症及可能的肝毒性。
Ann Pharmacother. 2006 Apr;40(4):753-7. doi: 10.1345/aph.1G462. Epub 2006 Mar 14.
5
Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.普伐他汀、辛伐他汀和阿托伐他汀与细胞色素P450抑制剂合用时的比较药代动力学相互作用概况。
Am J Cardiol. 2004 Nov 1;94(9):1140-6. doi: 10.1016/j.amjcard.2004.07.080.